Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.

Tereza EkrtováFilip BuršaPeter SklienkaJiří SaganMichelle VaňkováDenis BuršíkMarkéta BílenáMartin PulcerMichal BurdaJan Maca

Published in: Therapeutics and clinical risk management (2024)

Higher TTR and TATR were associated with better survival of critically ill patients with a severe course of COVID-19-associated pneumonia. Higher TBTR was associated with worse survival in these patients.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
chronic kidney disease
sars cov
peritoneal dialysis
venous thromboembolism
prognostic factors
early onset
free survival
growth factor
cell therapy
respiratory failure
drug induced